CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PFE

tucatinib

Phase 3
PFIZER (PFE)

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '27
PFEPhase 2

Tucatinib Phase 2 Est. Readout

tucatinib
Nov 2027~
CT.gov
00%
Apr '27
PFEPhase 2

Tucatinib Phase 2 Est. Readout

tucatinib
Apr 2027~
CT.gov
00%
Mar '27
PFEPhase 2

Tucatinib Phase 2 Est. Readout

tucatinib
Mar 2027~
CT.gov
00%
Competitive Landscape

3 competitors in HER2-positive Breast Cancer

View Full Landscape
Drug Information

Target Indication

HER2-positive Breast Cancer

Clinical Trial

NCT03975647

Last updated: 12/18/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.